Personalized Bone Organoid Using iPSC-Derived Cells
Author Information
Author(s): Gao Qi, Teissier Victoria, Zhu Wenjuan, Makarcyzk Meagan, Shinohara Issei, Murayama Masatoshi, Susuki Yosuke, Chow Simon, Bruce Bunnell, Wu Joy, Lin Hang
Hypothesis
Utilizing iPSC-derived cells for personalized bone formation research offers a powerful tool to better understand individual differences in bone health and disease.
Conclusion
Cells differentiated from iPSCs can be used to anticipate the effectiveness of cell-based therapies for personalized tissue regeneration.
Supporting Evidence
- iPSC-derived cells can replicate patient-specific characteristics.
- Different regenerative capacities were observed among cells from different donors.
Takeaway
Scientists are using special cells from patients to create bone models that can help understand how to better heal bones for each person.
Methodology
Generated iPSC-derived mesenchymal progenitor cells, endothelial cells, and macrophages from different donors and co-cultured them in a 3D in vitro model.
Participant Demographics
Different donors were used to generate the iPSC-derived cells.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website